28 results
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced additions to its executive leadership team, reflecting Provectus’s dedication to enhancing
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
the leadership of Jean-Marie Parel, IngETS-G, Ph.D., FARVO, Director of the Ophthalmic Biophysics Center (“OBC”) at Bascom Palmer Eye Institute (“BPEI
8-K
y3z9mae
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
EX-99.1
0vjqrx1r4y1e fsyw1fx
16 Jul 20
Provectus Biopharmaceuticals Announces Change to Board of Directors
8:00am
8-K
EX-99.1
q81s648duicy4
17 Dec 13
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware
12:00am